Evaluation of serological prenatal screening to detect toxoplasma gondii infections in Austria

Neonatology

Volumn 103, Issue 1, 2012, Pages 27-34

  Prusa, Andrea Romana ^a   Kasper, David C ^a   Olischar, Monika ^a   Husslein, Peter ^b   Pollak, Arnold ^a   Hayde, Michael ^a  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

Congenital toxoplasmosis; Gestational infection; Prenatal screening; Toxoplasma gondii

Indexed keywords

ANTIBIOTIC AGENT; DYE; IMMUNOGLOBULIN M; SABIN FELDMAN DYE; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRIA; BIRTH; CLINICAL EVALUATION; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FETUS; FETUS BLOOD; FETUS ECHOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOSORBENT AGGLUTINATION ASSAY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SEROLOGY; SYMPTOM; TOXOPLASMA GONDII; TOXOPLASMOSIS; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION;

ADULT; ALGORITHMS; AUSTRIA; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; YOUNG ADULT;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84866687361     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000342625     Document Type: Article

References (25)

1. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, Jalbrzikowski J, Remington J, Heydemann P, Noble AG, Mets M, Holfels E, Withers S, Latkany P, Meier P: Outcome of treatment for congenital toxoplasmosis, 1981-2004: the national collaborative Chicago-based, congenital toxoplasmosis study. Clin Infect Dis 2006; 42: 1383-1394.
2. Edelhofer R, Prossinger H: Infection with Toxoplasma gondii during pregnancy: seroepidemiological studies in Austria. Zoonoses Public Health 2010; 57: 18-26.
3. Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, Sautter M, Noble AG, Withers S, Swisher C, Heydemann P, Hosten T, Babiarz J, Lee D, Meier P, McLeod R: Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis 2011; 53: 1081-1089.
4. Hofhuis A, van Pelt W, van Duynhoven YT, Nijhuis CD, Mollema L, van der Klis FR, Havelaar AH, Kortbeek LM: Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect 2010; 139: 530-538.
5. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R: Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829-1833. (Pubitemid 29251014)
6. Gilbert R, Dezateux C: Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established. Arch Dis Child 2006; 91: 629-631.
7. Lopez A, Dietz VJ, Wilson M, Navin TR, Jones JL: Preventing congenital toxoplasmosis. MMWR Recomm Rep 2000; 49: 59-68.
8. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V: Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 2010; 15: 19600.
9. Benard A, Petersen E, Salamon R, Chene G, Gilbert R, Salmi LR: Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill 2008; 13: 18834.
10. Stillwaggon E, Carrier CS, Sautter M, McLeod R: Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis 2011; 5:e1333.
11. Thalhammer O, Heller-Szollosy E: Routine toxoplasmosis screening in pregnancy to prevent congenital infection: a prospective study (author's transl). Wien Klin Wochenschr 1979; 91: 20-25. (Pubitemid 9081830)
12. Aspock H, Husslein P, Janisch H, Mose JR, Pollak A, Vander-Mose A, Winter R: Toxoplasmosis. Recommendations for treatment of primary toxoplasma infection in pregnancy and congenital toxoplasmosis. Gynakol Geburtshilfliche Rundsch 1994; 34: 50-51.
13. Aspock H, Pollak A: Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl 1992; 84: 32-37. (Pubitemid 23048970)
14. Sagel U, Kramer A, Mikolajczyk RT: Incidence of maternal toxoplasma infections in pregnancy in upper Austria, 2000-2007. BMC Infect Dis 2011; 11: 348.
15. Reiter-Owona I, Petersen E, Joynson D, Aspock H, Darde ML, Disko R, Dreazen O, Dumon H, Grillo R, Gross U, Hayde M, Holliman R, Ho-Yen DO, Janitschke K, Jenum PA, Naser K, Olszewski M, Thulliez P, Seitz HM: The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ 1999; 77: 929-935.
16. Sabin AB, Feldman HA: Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (toxoplasma). Science 1948; 108: 660-663.
17. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E: Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European research network on congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996; 15: 799-805. (Pubitemid 26386122)
18. Campello Porto L, Duarte EC: Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994-2009. Int J Infect Dis 2012; 16:e480-486.
19. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE: Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 2010; 7.
20. Foulon W, Naessens A, Ho-Yen D: Prevention of congenital toxoplasmosis. J Perinat Med 2000; 28: 337-345. (Pubitemid 32952974)
21. Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, Petersen E, Gilbert R: Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 2005; 94: 1721-1731. (Pubitemid 43155582)
22. Hotop A, Hlobil H, Gross U: Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2012; 54: 1545-1552.
23. Montoya JG, Remington JS: Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008; 47: 554-566.
24. Kasper DC, Prusa AR, Hayde M, Gerstl N, Pollak A, Herkner KR, Reiter-Reisacher R: Evaluation of the vitros ECiQ immunodiagnostic system for detection of anti-toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. J Clin Microbiol 2009; 47: 164-167.
25. Prusa AR, Hayde M, Unterasinger L, Pollak A, Herkner KR, Kasper DC: Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational toxoplasma infection. Diagn Microbiol Infect Dis 2010; 68: 352-357.